Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
Crossref DOI link: https://doi.org/10.1007/s10549-016-3954-1
Published Online: 2016-08-30
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Younis, T.
Rayson, D.
Jovanovic, S.
Skedgel, C.
Funding for this research was provided by:
Atlantic Clinical Cancer Research Unit
License valid from 2016-08-30